Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Avril

Showing results (131-140 of 199) with videos related to

Pageof 20
Sort By:
Cancer|November 1, 1990
Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastasesC Jacquillat, D Khayat, P Banzet, et al.
Archives of Dermatology|November 1, 1996
Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entitiesV Callot, J C Roujeau, M Bagot, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Chemotherapy by fotemustine in cerebral metastases of disseminated malignant melanomaC Jacquillat, D Khayat, P Banzet, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1993
[Erysipelas-like eruption with hyperleukocytosis and fever: a new paraneoplastic syndrome in melanoma?]L Ollivaud, J C Ortoli, P Saiag, et al.
The Journal of Investigative Dermatology|March 12, 2002
Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligoF A Le Gal, M F Avril, J Bosq, et al.
Oncogene|August 6, 2008
Heterozygous mutations in the tumor suppressor gene PATCHED provoke basal cell carcinoma-like features in human organotypic skin culturesF Brellier, V Bergoglio, A Valin, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1985
[Buschke-Löwenstein tumor. 3 vulvar localizations. Association with HPV-6 in one case]A Mathieu, M F Avril, P Duvillard, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
A phase I trial with recombinant interferon gamma (Roussel UCLAF) in advanced cancer patientsF Boue, Z Pastran, M Spielmann, et al.
Oncogene|September 20, 2006
Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activationA Hamaï, C Richon, F Meslin, et al.
The British Journal of Dermatology|November 9, 2000
Leucoderma associated with flares of erythrodermic cutaneous T-cell lymphomas: four cases. The French Study Group of Cutaneous LymphomasA Bouloc, F Grange, M H Delfau-Larue, et al.
Pageof 20

Showing results (131-140 of 199) with videos related to

Sort By:
Pageof 20
Cancer|November 1, 1990
Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastasesC Jacquillat, D Khayat, P Banzet, et al.
Archives of Dermatology|November 1, 1996
Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entitiesV Callot, J C Roujeau, M Bagot, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Chemotherapy by fotemustine in cerebral metastases of disseminated malignant melanomaC Jacquillat, D Khayat, P Banzet, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1993
[Erysipelas-like eruption with hyperleukocytosis and fever: a new paraneoplastic syndrome in melanoma?]L Ollivaud, J C Ortoli, P Saiag, et al.
The Journal of Investigative Dermatology|March 12, 2002
Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligoF A Le Gal, M F Avril, J Bosq, et al.
Oncogene|August 6, 2008
Heterozygous mutations in the tumor suppressor gene PATCHED provoke basal cell carcinoma-like features in human organotypic skin culturesF Brellier, V Bergoglio, A Valin, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1985
[Buschke-Löwenstein tumor. 3 vulvar localizations. Association with HPV-6 in one case]A Mathieu, M F Avril, P Duvillard, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
A phase I trial with recombinant interferon gamma (Roussel UCLAF) in advanced cancer patientsF Boue, Z Pastran, M Spielmann, et al.
Oncogene|September 20, 2006
Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activationA Hamaï, C Richon, F Meslin, et al.
The British Journal of Dermatology|November 9, 2000
Leucoderma associated with flares of erythrodermic cutaneous T-cell lymphomas: four cases. The French Study Group of Cutaneous LymphomasA Bouloc, F Grange, M H Delfau-Larue, et al.
Pageof 20